RESVO

Japanese

LABORATORY

Challenge to drug development for neuropsychiatric disorders caused by immune diseases

Schizophrenia is one of the most serious mental disorder. The number of schizophrenia patients is 1% of the world population. It has been recognized that schizophrenia is a neuro-origin disorder for long time. 20 years ago, researchers have found that there is a group of schizophrenia caused by immune disorder. However, we have not gotten the method to completely cure yet. Recently, at Shimane Univercity, it has been discovered that drugs acting on immunity to some schizophrenic patients and bone marrow transplantation are effective. Therefore, we set up a joint labolatory with RESVO and ShimaneUnivercity, who have strengths in basic research on immune disorder schizophrenia, and develop new treatments.

LABORATORY
MEMBER

OH-NISHI ARATA
Research Professor (basic science) Neuroscience, Neuroimmunology, Proteomics
HORIGUCHI JUN
Research Professor (clinical science)neuropsychiatry
MAEDA TADAKAZU
Research advisorDisease proteomics
MIYAOKA TSUYOSHI
department of psychiatry associate professorneuropsychiatry

RESEARCH GOALS

研究目標

従来の治療の流れ
RESVOの検査キットを使った治療の流れ

ACCESS

島根大学 医学部 免疫精神神経学共同研究室

住所
〒693-0021 島根県出雲市塩冶町89−1
設立
2018年1月5日
CONTACT

Please visit our contact page for potential research partnering and collaborating.

Contact Us